Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C-Reference-Cited by-同舟云学术

Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C

Published:2018-11 Issue:5 Volume:69 Page:1088-1098
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ioannou George N.,Green Pamela K.,Beste Lauren A.,Mun Elijah J.,Kerr Kathleen F.,Berry Kristin

Publisher

Elsevier BV

Subject

Hepatology

Reference48 articles.

1. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma;Ioannou;J Hepatol,2018

2. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

3. Bruix J, Sherman M. AASLD Practice guideline. Management of hepatocellular carcinoma: an update. Available at: http://www.aasld.org/sites/default/files/guideline_documents/HCCUpdate2010.pdf; 2011.

4. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

5. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance;Marks;AJR Am J Roentgenol,2015

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs;Annals of Hepatology;2024-09

2. Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility;Journal of Gastroenterology and Hepatology;2024-08-27

3. Liver and spleen stiffness measurement in the prediction of hepatocellular carcinoma in chronic liver disease;Exploration of Digestive Diseases;2024-08-21

4. Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort study;eClinicalMedicine;2024-08

5. High serum gamma‐glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma;Hepatology Research;2024-07-29